Divjot Kaur retweeted
Our paper out in @EvolLetters 🎉
Antibiotic resistance poses threats to public health, making infection harder to treat. But how does resistance impact a pathogen’s ability to invade other bacteria (i.e. microbiome)?
doi.org/10.1093/evlett/qrae0…
By Lindon, @dannagifford, @Divjot_K, @aoliverp73, @WheatleyRM et al.
Divjot Kaur retweeted
🚨 Pop Up Oxford! 🚨 A (free!) microbial genomics conference, with a focus on early career researchers - abstract submissions now open 🦠🧬 – at Oxford, England
📢MicrobesNG POPUP Conference is coming to Oxford! This is a FREE #MicrobialGenomics conference on 7th Mar 🦠🧬. We're accepting abstracts for talks now! Focus on ECRs. Please RT!
Submit abstract by 6th Dec 👉 surveymonkey.co.uk/r/Oxford_…
Organised by @RWheatley8
#MNGPopUp #ECR
Divjot Kaur retweeted
New research out now in @ISMEJournal from @CraigMacLean9, @stephan_uphoff, @pramod_k_jangir, @Divjot_K, @E_colicious et al!
"Regulatory fine-tuning of mcr-1 increases bacterial fitness and stabilises #antibiotic resistance in agricultural settings"🧬💊⤵️
nature.com/articles/s41396-0…
Divjot Kaur retweeted
*Preprint Alert* This one’s in a new area for the lab: phage editing! We're using retrons to produce recombineering donors ~inside~ bacterial hosts. A wild-type phage infects the host and an edited phage comes out. biorxiv.org/content/10.1101/…
Best birthday #27 💕 Thank you to all my lovely lab friends for making it so special @RWheatley8 @E_colicious
Divjot Kaur retweeted
Day of #earlycareerresearcher firsts: decision back on my first senior author paper, written with a brilliant masters student supervised last year on a remote project 🥳 (first ever masters student!). First time submitting with @MicrobioSoc , & the process so far has been great – at Oxford, England
Divjot Kaur retweeted
Move over CRISPR, the retrons are coming. Researchers have harnessed this genetic quirk from bacteria to create a DNA editing tool that allows them to perform and track millions of experiments in a single test tube. wyss.harvard.edu/news/move-o…
Divjot Kaur retweeted
Now in PNAS with a few extra goodies, for the afficionados:
pnas.org/content/118/18/e201…
Excited to share our pre-print, describing using ssDNA made inside cells to perform new types of high-throughput screens in bacteria!
With @dbgoodman @TimWannier @Divjot123 Fahim Farzadfard @timlu @seth_shipman @geochurch
(science thread, if you care)
biorxiv.org/content/10.1101/…
So grateful to be a part of this amazing work! 🧬
So pleased to share the first article coming out of the Alberti lab, on engineering isoprenoid quinone production in yeast: pubs.acs.org/doi/abs/10.1021…
@Divjot_K @duha20122282 @CorreLabo
@LeverhulmeTrust @WarwickLifeSci @warwickchem.
🔬🧬🧫
Exciting! Retrons function as anti- phage defense #progress
After more than three decades of mystery, we are happy to report that we discovered the function of some of the coolest bacterial elements - retrons.
Retrons function as anti-phage defense systems!
See our new preprint biorxiv.org/cgi/content/shor…
@AdiMillman @AudeBer @AAvihail
Divjot Kaur retweeted
Scientists @UniofOxford have developed rapid testing technology for #COVID-19.
The team, led by Prof. Zhanfeng Cui and Prof. Wei Huang (@oxengsci & OSCAR) have been working to improve test capabilities as the virus spreads: bit.ly/2vuPRVQ
So excited that this pre-print is out !Amazing job by @Schubes0 and team 😁
Make sure to give it a read !
biorxiv.org/content/10.1101/…
Divjot Kaur retweeted
Excited to share our pre-print, describing using ssDNA made inside cells to perform new types of high-throughput screens in bacteria!
With @dbgoodman @TimWannier @Divjot123 Fahim Farzadfard @timlu @seth_shipman @geochurch
(science thread, if you care)
biorxiv.org/content/10.1101/…
Divjot Kaur retweeted
Our latest work on isoprenoid quinone production in yeast is now available on @biorxivpreprint! 🧫🧬
Check it out here biorxiv.org/content/10.1101/… - feedback welcome.
@Divjot_K @CorreLabo @WarwickLifeSci @warwickchem



















